{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:6cfc4978-4f0a-45f0-bc43-82ca96fdde88", "type": "composite", "version": "1", "versioncreated": "2026-11-06T12:45:12.057297Z", "firstcreated": "2026-11-06T12:45:12.057297Z", "pubstatus": "usable", "language": "en", "headline": "Low-dose rapamycin improves brain blood flow in middle-aged adults at Alzheimer's risk", "description_text": "A small early study found that four weeks of low-dose rapamycin improved blood flow in the brains of healthy middle-aged adults carrying the APOE4 gene variant, with the strongest effect seen in women.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:7b6d8cd6-4317-4e04-bbd1-a630a7ae074f", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-11-06T12:45:37.551997Z", "firstcreated": "2026-11-06T12:45:12.057297Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "Low-dose rapamycin improves brain blood flow in middle-aged adults at Alzheimer's risk", "byline": "Kelsey Sawyer", "located": "United States", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Science Official", "usageterms": "Monitoring item. Headline, short extract and the source link may be shown. Do not republish the full text.", "description_text": "A small early study found that four weeks of low-dose rapamycin improved blood flow in the brains of healthy middle-aged adults carrying the APOE4 gene variant, with the strongest effect seen in women.", "altids": {"mosaic": "7b6d8cd6-4317-4e04-bbd1-a630a7ae074f", "story": "6cfc4978-4f0a-45f0-bc43-82ca96fdde88", "slug": "low-dose-rapamycin-improves-brain-blood-flow-in-middle-aged-adults-at-alzheimer-s-risk"}, "subject": [{"name": "Health", "rel": "direct", "literal": "health", "code": "medtop:07000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/07000000"}], "place": [{"name": "United States", "literal": "us", "code": "US", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "body_text": "A small early study found that four weeks of low-dose rapamycin improved blood flow in the brains of healthy middle-aged adults carrying the APOE4 gene variant, with the strongest effect seen in women.", "extra_body_note": "Extract only — see rights.class = link_only.", "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:d71bf1af-5acb-4676-96e4-8026dd296b2d", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Scientists discover new Alzheimer’s drug that repairs DNA damage and reduces brain inflammation", "description_text": "Experimental Alzheimer’s drug repairs DNA damage and reduces brain inflammation", "copyrightholder": "commons.wikimedia.org", "copyrightnotice": "Vertenflow", "usageterms": "Public domain work (government or dedicated). Credit appreciated, not required.", "altids": {"wireva": "d71bf1af-5acb-4676-96e4-8026dd296b2d"}, "extra": {"wireva:delivery_mode": "file", "wireva:rights": {"licence": "Public domain", "licence_url": "https://creativecommons.org/publicdomain/mark/1.0/", "licence_raw": "CC0", "licence_verified_at": "2026-11-06T12:45:37.651120Z", "attribution_required": false, "attribution_text": "Vertenflow", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "commons.wikimedia.org", "source_url": "https://commons.wikimedia.org/wiki/File:Brain-ALZH.svg", "source_page_url": "https://commons.wikimedia.org/wiki/File:Brain-ALZH.svg", "our_page_url": "https://scienceofficial.org/medicine/low-dose-rapamycin-improves-brain-blood-flow-in-middle-aged-adults-at-alzheimer-s-risk/"}, "wireva:role": "lead"}, "renditions": {"original": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/9b5502f85d47a61737634092f449ab76195d416a9d4f33504d6f006f9c0315d9.jpg", "mimetype": "image/jpeg", "width": 1280, "height": 864, "sizeinbytes": 124027}, "source": {"href": "https://commons.wikimedia.org/wiki/File:Brain-ALZH.svg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:6cfc4978-4f0a-45f0-bc43-82ca96fdde88", "slug": "low-dose-rapamycin-improves-brain-blood-flow-in-middle-aged-adults-at-alzheimers-risk-20261106", "status": "developing", "languages": ["en"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "link_only", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Science Official", "canonical_required": true, "canonical_url": "https://scienceofficial.org/medicine/low-dose-rapamycin-improves-brain-blood-flow-in-middle-aged-adults-at-alzheimer-s-risk/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 280, "decided_by_rule": "derivation_failed", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "single_source", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.", "independence_check": {"status": "failed", "score": 0.698, "checked_at": "2026-11-06T12:45:37.632866Z"}, "sources": [{"url": "https://www.sciencedaily.com/releases/2026/11/261104084017.htm", "title": "An anti-aging drug may help protect the brain before Alzheimer's symptoms begin", "publisher": "sciencedaily.com", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-11-06T12:45:37.572234Z", "published_at": "2026-11-06T00:11:19Z"}]}, "wireva:publication": {"name": "Science Official", "domain": "scienceofficial.org", "country": "US", "url": "https://scienceofficial.org/medicine/low-dose-rapamycin-improves-brain-blood-flow-in-middle-aged-adults-at-alzheimer-s-risk/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/7b6d8cd6-4317-4e04-bbd1-a630a7ae074f", "html": "https://wireva.mib.news/item/7b6d8cd6-4317-4e04-bbd1-a630a7ae074f/low-dose-rapamycin-improves-brain-blood-flow-in-middle-aged-adults-at-alzheimer-s-risk/", "story": "https://wireva.mib.news/story/low-dose-rapamycin-improves-brain-blood-flow-in-middle-aged-adults-at-alzheimers-risk-20261106/"}, "wireva:metrics": {"word_count": 240, "char_count": 1533, "reading_time_seconds": 110}}}}, "extra": {"wireva:languages": ["en"], "wireva:status": "developing", "wireva:item_count": 1}}